18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Long-term effects of donepezil on P300 auditory event-related potentials in patients with Alzheimer's disease.

      Journal of geriatric psychiatry and neurology
      Aged, Aged, 80 and over, Alzheimer Disease, drug therapy, physiopathology, psychology, Cholinesterase Inhibitors, pharmacology, Event-Related Potentials, P300, drug effects, Evoked Potentials, Auditory, Female, Follow-Up Studies, Humans, Indans, Male, Neuropsychological Tests, statistics & numerical data, Piperidines, Time Factors

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The P300, one of the cognitive event-related potentials (ERPs) of the cerebral cortex, reflects the functioning of the neurochemical system involved in cognitive processes. We investigated clinical significance of the components of auditory P300 ERPs, in comparison with neuropsychologic tests including the Mini-Mental State Examination and the Japanese version of the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-J cog), for evaluating of the effect of donepezil (DPZ) (5 mg daily for 6 months), an acetylcholinesterase inhibitor, in patients with Alzheimer's disease (AD). Reduction of P300 latency associated with a parallel improvement of ADAS-J cog scores was observed after administration of 5 mg/day of DPZ in patients with AD. P300 latency gives very useful information on the progression of AD, especially in the longitudinal follow-up of patients with AD during treatment with DPZ acting on cholinergic pathways.

          Related collections

          Author and article information

          Comments

          Comment on this article